Literature DB >> 10490983

Mapping the major interaction between binding protein and Ig light chains to sites within the variable domain.

D P Davis1, R Khurana, S Meredith, F J Stevens, Y Argon.   

Abstract

Newly synthesized Ig chains are known to interact in vivo with the binding protein (BiP), a major peptide-binding chaperone in the endoplasmic reticulum. The predominant interactions between the light chain and BiP are observed early in the folding pathway, when the light chain is either completely reduced, or has only one disulfide bond. In this study, we describe the in vitro reconstitution of BiP binding to the variable domain of light chains (VL). Binding of deliberately unfolded VL was dramatically more avid than that of folded VL, mimicking the interaction in vivo. Furthermore, VL binding was inhibited by addition of ATP, was competed with excess unlabeled VL, and was demonstrated with several different VL proteins. Using this assay, peptides derived from the VL sequence were tested experimentally for their ability to bind BiP. Four peptides from both beta sheets of VL were shown to bind BiP specifically, two with significantly higher affinity. As few as these two peptide sites, one from each beta sheet of VL, are sufficient to explain the association of BiP with the entire light chain. These results suggest how BiP directs the folding of Ig in vivo and how it may be used in shaping the B cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490983

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum.

Authors:  Michal Marzec; Davide Eletto; Yair Argon
Journal:  Biochim Biophys Acta       Date:  2011-11-03

2.  Quantitative Interactome Proteomics Reveals a Molecular Basis for ATF6-Dependent Regulation of a Destabilized Amyloidogenic Protein.

Authors:  Lars Plate; Bibiana Rius; Bianca Nguyen; Joseph C Genereux; Jeffery W Kelly; R Luke Wiseman
Journal:  Cell Chem Biol       Date:  2019-05-16       Impact factor: 8.116

3.  ERdj3 regulates BiP occupancy in living cells.

Authors:  Feng Guo; Erik L Snapp
Journal:  J Cell Sci       Date:  2013-02-01       Impact factor: 5.285

Review 4.  Orchestration of secretory protein folding by ER chaperones.

Authors:  Tali Gidalevitz; Fred Stevens; Yair Argon
Journal:  Biochim Biophys Acta       Date:  2013-03-15

5.  Decreased secretion and unfolded protein response up-regulation are correlated with intracellular retention for single-chain antibody variants produced in yeast.

Authors:  Ping Xu; Anne Skaja Robinson
Journal:  Biotechnol Bioeng       Date:  2009-09-01       Impact factor: 4.530

6.  Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains.

Authors:  J L Dul; D P Davis; E K Williamson; F J Stevens; Y Argon
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

7.  BiP clustering facilitates protein folding in the endoplasmic reticulum.

Authors:  Marc Griesemer; Carissa Young; Anne S Robinson; Linda Petzold
Journal:  PLoS Comput Biol       Date:  2014-07-03       Impact factor: 4.475

8.  AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.

Authors:  Jonathan S Wall; Stephen J Kennel; Angela Williams; Tina Richey; Alan Stuckey; Ying Huang; Sallie Macy; Robert Donnell; Robin Barbour; Peter Seubert; Dale Schenk
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

9.  Structures of insect Imp-L2 suggest an alternative strategy for regulating the bioavailability of insulin-like hormones.

Authors:  Nikolaj Kulahin Roed; Cristina M Viola; Ole Kristensen; Gerd Schluckebier; Mathias Norrman; Waseem Sajid; John D Wade; Asser Sloth Andersen; Claus Kristensen; Timothy R Ganderton; Johan P Turkenburg; Pierre De Meyts; Andrzej M Brzozowski
Journal:  Nat Commun       Date:  2018-09-21       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.